Please enable JavaScript to continue using this application.

Compare $CMPX vs $ELDN | Chartloom

Compare

$CMPX vs $ELDN

Compass Therapeutics Inc. · Eledon Pharmaceuticals Inc

CMPX

Compass Therapeutics Inc.

ELDN

Eledon Pharmaceuticals Inc

Compare $CMPX vs $ELDN

Comparing Compass Therapeutics Inc. and Eledon Pharmaceuticals Inc

CMPXCompass Therapeutics Inc.

ELDNEledon Pharmaceuticals Inc

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMPX

ELDN

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

ELDN

Eledon Pharmaceuticals Inc

Market Cap

CMPX$179M

ELDN$191M

Enterprise Value

CMPX$143M

ELDN$185M

Price

CMPX$0.99

ELDN$2.48

P/E Ratio

CMPXN/A

ELDNN/A

P/S Ratio

CMPX0.00x

ELDN0.00x

EV/Sales

CMPX0.00x

ELDN0.00x

EV/EBITDA

CMPX0.00x

ELDN0.00x

P/B Ratio

CMPX0.93x

ELDN2.81x

P/FCF Ratio

CMPXN/A

ELDNN/A

EV/FCF

CMPX-2.54x

ELDN-2.50x

PEG Ratio

CMPXN/A

ELDNN/A

Forward P/E (NTM)

CMPXN/A

ELDNN/A

Forward P/S (NTM)

CMPX1.51x

ELDNN/A

Revenue (TTM)

CMPX$0

ELDN$0

Revenue Growth (YoY)

CMPXN/A

ELDNN/A

Forward Rev Growth

CMPX397.5%

ELDN325.8%

Gross Margin (TTM)

CMPX0.0%

ELDN0.0%

Operating Margin (TTM)

CMPX0.0%

ELDN0.0%

EBITDA Margin (TTM)

CMPX0.0%

ELDN0.0%

Net Margin (TTM)

CMPX0.0%

ELDN0.0%

FCF Margin (TTM)

CMPXN/A

ELDNN/A

Net Income (TTM)

CMPX$-30M

ELDN$-99M

FCF (TTM)

CMPX$-56M

ELDN$-74M

EPS (TTM)

CMPX$0.00

ELDN-$0.87

ROE (TTM)

CMPX-2994.0%

ELDN-9848.0%

ROA (TTM)

CMPX-2635.0%

ELDN-6897.0%

ROIC (TTM)

CMPX-2994.0%

ELDN-9848.0%

Cash

CMPX$35M

ELDN$7M

Debt

CMPX$0

ELDN$0

Net Cash/Debt

CMPX$35M

ELDN$7M

Current Ratio (TTM)

CMPX11.22x

ELDN7.90x

Quick Ratio (TTM)

CMPX11.15x

ELDN7.60x

Debt/Equity (TTM)

CMPX0.00x

ELDN0.00x

Debt/Assets (TTM)

CMPX0.0%

ELDN0.0%

Interest Coverage (TTM)

CMPXN/A

ELDNN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

ELDN0.00x

Beta

CMPX1.07

ELDN1.01

52W Performance

CMPX-74.5%

ELDN-13.6%

YTD Performance

CMPX-80.8%

ELDN53.1%

% from 52W High

CMPX-85.6%

ELDN-46.1%

% from 52W Low

CMPX19.7%

ELDN83.7%

Asset Turnover (TTM)

CMPX0.00x

ELDN0.00x

FCF Yield (TTM)

CMPX-31.5%

ELDN-38.6%

Earnings Yield (TTM)

CMPX-16.8%

ELDN-51.5%

Dividend Yield (TTM)

CMPXN/A

ELDNN/A

Rule of 40

CMPX0.0

ELDN0.0

EV/GP/RG

CMPXN/A

ELDNN/A

Ticker research

View CMPX research View ELDN research

Metric	CMPX Compass Therapeutics Inc.	ELDN Eledon Pharmaceuticals Inc
Market & Valuation
Market Cap	$179M	$191M
Enterprise Value	$143M	$185M
Price	$0.99	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	2.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-2.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.5%	325.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-30M	$-99M
FCF (TTM)	$-56M	$-74M
EPS (TTM)	$0.00	-$0.87
ROE (TTM)	-2994.0%	-9848.0%
ROA (TTM)	-2635.0%	-6897.0%
ROIC (TTM)	-2994.0%	-9848.0%
Financial Health
Cash	$35M	$7M
Debt	$0	$0
Net Cash/Debt	$35M	$7M
Current Ratio (TTM)	11.22x	7.90x
Quick Ratio (TTM)	11.15x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.01
52W Performance	-74.5%	-13.6%
YTD Performance	-80.8%	53.1%
% from 52W High	-85.6%	-46.1%
% from 52W Low	19.7%	83.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.5%	-38.6%
Earnings Yield (TTM)	-16.8%	-51.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View ELDN research

Valuation

P/S Ratio

CMPX

0.00x

ELDN

0.00x

EV/FCF

CMPX

-2.54x

ELDN

-2.50x

Growth & revenue

Forward Revenue Growth

CMPX

397.5%

ELDN

325.8%

Profitability & performance

Gross Margin

CMPX

0.0%

ELDN

0.0%

ROE

CMPX

-2994.0%

ELDN

-9848.0%

FCF Yield %

CMPX

-31.5%

ELDN

-38.6%

52-Week Performance

ELDN

-13.6%

CMPX

-74.5%

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

ELDN

Eledon Pharmaceuticals Inc

Market Cap

CMPX$179M

ELDN$191M

Enterprise Value

CMPX$143M

ELDN$185M

Price

CMPX$0.99

ELDN$2.48

P/E Ratio

CMPXN/A

ELDNN/A

P/S Ratio

CMPX0.00x

ELDN0.00x

EV/Sales

CMPX0.00x

ELDN0.00x

EV/EBITDA

CMPX0.00x

ELDN0.00x

P/B Ratio

CMPX0.93x

ELDN2.81x

P/FCF Ratio

CMPXN/A

ELDNN/A

EV/FCF

CMPX-2.54x

ELDN-2.50x

PEG Ratio

CMPXN/A

ELDNN/A

Forward P/E (NTM)

CMPXN/A

ELDNN/A

Forward P/S (NTM)

CMPX1.51x

ELDNN/A

Revenue (TTM)

CMPX$0

ELDN$0

Revenue Growth (YoY)

CMPXN/A

ELDNN/A

Forward Rev Growth

CMPX397.5%

ELDN325.8%

Gross Margin (TTM)

CMPX0.0%

ELDN0.0%

Operating Margin (TTM)

CMPX0.0%

ELDN0.0%

EBITDA Margin (TTM)

CMPX0.0%

ELDN0.0%

Net Margin (TTM)

CMPX0.0%

ELDN0.0%

FCF Margin (TTM)

CMPXN/A

ELDNN/A

Net Income (TTM)

CMPX$-30M

ELDN$-99M

FCF (TTM)

CMPX$-56M

ELDN$-74M

EPS (TTM)

CMPX$0.00

ELDN-$0.87

ROE (TTM)

CMPX-2994.0%

ELDN-9848.0%

ROA (TTM)

CMPX-2635.0%

ELDN-6897.0%

ROIC (TTM)

CMPX-2994.0%

ELDN-9848.0%

Cash

CMPX$35M

ELDN$7M

Debt

CMPX$0

ELDN$0

Net Cash/Debt

CMPX$35M

ELDN$7M

Current Ratio (TTM)

CMPX11.22x

ELDN7.90x

Quick Ratio (TTM)

CMPX11.15x

ELDN7.60x

Debt/Equity (TTM)

CMPX0.00x

ELDN0.00x

Debt/Assets (TTM)

CMPX0.0%

ELDN0.0%

Interest Coverage (TTM)

CMPXN/A

ELDNN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

ELDN0.00x

Beta

CMPX1.07

ELDN1.01

52W Performance

CMPX-74.5%

ELDN-13.6%

YTD Performance

CMPX-80.8%

ELDN53.1%

% from 52W High

CMPX-85.6%

ELDN-46.1%

% from 52W Low

CMPX19.7%

ELDN83.7%

Asset Turnover (TTM)

CMPX0.00x

ELDN0.00x

FCF Yield (TTM)

CMPX-31.5%

ELDN-38.6%

Earnings Yield (TTM)

CMPX-16.8%

ELDN-51.5%

Dividend Yield (TTM)

CMPXN/A

ELDNN/A

Rule of 40

CMPX0.0

ELDN0.0

EV/GP/RG

CMPXN/A

ELDNN/A

Ticker research

View CMPX research View ELDN research

Metric	CMPX Compass Therapeutics Inc.	ELDN Eledon Pharmaceuticals Inc
Market & Valuation
Market Cap	$179M	$191M
Enterprise Value	$143M	$185M
Price	$0.99	$2.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	2.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-2.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.5%	325.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-30M	$-99M
FCF (TTM)	$-56M	$-74M
EPS (TTM)	$0.00	-$0.87
ROE (TTM)	-2994.0%	-9848.0%
ROA (TTM)	-2635.0%	-6897.0%
ROIC (TTM)	-2994.0%	-9848.0%
Financial Health
Cash	$35M	$7M
Debt	$0	$0
Net Cash/Debt	$35M	$7M
Current Ratio (TTM)	11.22x	7.90x
Quick Ratio (TTM)	11.15x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.01
52W Performance	-74.5%	-13.6%
YTD Performance	-80.8%	53.1%
% from 52W High	-85.6%	-46.1%
% from 52W Low	19.7%	83.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.5%	-38.6%
Earnings Yield (TTM)	-16.8%	-51.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View ELDN research